BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 465055)

  • 1. Monoclonal antibodies against purified nicotinic acetylcholine receptor.
    Gomez CM; Richman DP; Berman PW; Burres SA; Arnason BG; Fitch FW
    Biochem Biophys Res Commun; 1979 May; 88(2):575-82. PubMed ID: 465055
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies directed against the neurotransmitter binding site of nicotinic acetylcholine receptor.
    James RW; Kato AC; Rey MJ; Fulpius BW
    FEBS Lett; 1980 Oct; 120(1):145-8. PubMed ID: 7439383
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal anti-acetylcholine receptor antibodies can cause experimental myasthenia.
    Richman DP; Gomez CM; Berman PW; Burres SA; Fitch FW; Arnason BG
    Nature; 1980 Aug; 286(5774):738-9. PubMed ID: 7412861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.
    Lennon VA; Lambert EH
    Nature; 1980 May; 285(5762):238-40. PubMed ID: 6154894
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis under monoclonal scrutiny.
    Lewin R
    Science; 1981 Jan; 211(4477):38-40, 42. PubMed ID: 6160615
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 9. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis, the acetylcholine receptor and the immune response.
    Barkas T
    Int J Immunopharmacol; 1979; 1(4):263-71. PubMed ID: 162144
    [No Abstract]   [Full Text] [Related]  

  • 12. Absence of acetylcholine receptor antibody in relatives of myasthenic patients.
    Walker GL; Nicholson LV; Mastaglia FL
    Lancet; 1980 Apr; 1(8171):778-9. PubMed ID: 6103204
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.
    Fulpius BW; Miskin R; Reich E
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4326-30. PubMed ID: 6933485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.
    de Crousaz G; Fulpius BW
    Lancet; 1978 Jan; 1(8054):47. PubMed ID: 74528
    [No Abstract]   [Full Text] [Related]  

  • 15. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the understanding of myasthenia gravis pathogenesis.
    Heilbronn E
    Prog Clin Biol Res; 1980; 39():391-405. PubMed ID: 6995993
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology of the nicotinic acetylcholine receptor.
    Fuchs S
    Curr Top Microbiol Immunol; 1979; 85():1-29. PubMed ID: 114357
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
    Loutrari H; Kokla A; Trakas N; Tzartos SJ
    Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Properties of nicotinic acetylcholine receptors isolated by affinity chromatography on monoclonal antibodies.
    Lennon VA; Thompson M; Chen J
    J Biol Chem; 1980 May; 255(10):4395-8. PubMed ID: 6966279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.